Search - tctmd.com

Displaying 1 - 8 of 8

Sort: Relevancy | Date

Presentation Controversies and Advances 2019

CCTA/ FFRct for complex CAD

Presenter: Jonathon Leipsic

November 15, 2019

Presentation TCT Abstracts Posters 2019

The Effect of Prior Percutaneous Coronary Intervention on Pulmonary Artery Systolic Pressure and Ejection Fraction After Transcatheter Aortic Valve Replacement

Presenter: Cecillia Y Wong

October 28, 2019

Presentation TCT Abstracts Posters 2019

Distribution of coronary artery disease in patients with low-risk transcatheter aortic valve replacement: A computed tomography coronary angiography study (from the LRT trial)

Presenter: Yuichi Ozaki

September 29, 2019

Presentation

Antithrombotic Therapy and CV Outcomes After TAVR in A-fib Patients

August 20, 2019

Presentation SIF 2019

Sometimes TAVR Requires Immediate Coronary Intervention

Presenter: Maulik G. Shah

March 28, 2019

Presentation LAA 2017

Left Atrial Appendage Occlusion as Adjunctive Therapy

Presenter: Amar Krishnaswamy

July 21, 2017

Presentation EuroPCR 2017

Efficacy and Safety of LAA Closure with WATCHMAN in Patients with or without Contraindication to Oral Anticoagulation: 1-year FU of the EWOLUTION trial

Presenter: Lucas Boersma, Martin W. Bergmann

May 18, 2017

Presentation

Warfarin and Antiplatelet Therapy vs Warfarin Alone for Treating Patients with A-fib Undergoing TAVR

Presenter: Abdul-Jawad Altisent

August 16, 2016

Advertisement

CCTA/ FFRct for complex CAD

The Effect of Prior Percutaneous Coronary Intervention on Pulmonary Artery Systolic Pressure and Ejection Fraction After Transcatheter Aortic Valve Replacement

Distribution of coronary artery disease in patients with low-risk transcatheter aortic valve replacement: A computed tomography coronary angiography study (from the LRT trial)

Antithrombotic Therapy and CV Outcomes After TAVR in A-fib Patients

Sometimes TAVR Requires Immediate Coronary Intervention

Left Atrial Appendage Occlusion as Adjunctive Therapy

Efficacy and Safety of LAA Closure with WATCHMAN in Patients with or without Contraindication to Oral Anticoagulation: 1-year FU of the EWOLUTION trial

Warfarin and Antiplatelet Therapy vs Warfarin Alone for Treating Patients with A-fib Undergoing TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content